API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. BIOA.NASDAQ

BioAge Labs, Inc (BIOA NASDAQ) stock market data APIs

$19.5 0.21(1.1%) as of November 27, 2024
Price chart is built with Anychart

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

BioAge Labs, Inc Financial Data Overview

19.29
19.5
-
19.54
18.824
18-26.62
674 M
34 167 K
0
-0.6845
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BIOA',
Type: 'Common Stock',
Name: 'BioAge Labs, Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00HBTB0M9',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2024-09-26',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

BioAge Labs, Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -51 394 000
  • Earnings Per Share -5.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get BioAge Labs, Inc Earnings via APIs

  • Latest Release 2024-11-08
  • EPS/Forecast NaN

Get BioAge Labs, Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get BioAge Labs, Inc latest news via APIs

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against BioAmber Inc. (BIOA) & Lead Plaintiff Deadline: May 17, 2017

  • BRONSTEIN
  • CLASS ACTION
  • GEWIRTZ & GROSSMAN
  • LLC

The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of BioAmber Inc. Shareholders and a Lead Plaintiff Deadline of May 17, 2017 (BIOA)

NEW YORK, April 27, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of BioAmber Inc. (NYSE:BIOA) who purchased shares pur...
  • CLASS ACTION
  • THE KLEIN LAW FIRM
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com